ALERTS: DISTRIBUTION - CENTRAL CONTRACTING AGENCY – COMMISSIONER – PRICE DISCRIMINATION

General conditions of sale: The Paris Court of Appeal reviews the legality of the general conditions of sales by client categories’ criteria and their implementation (Pyxis Pharma / Cooper)

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. The Cooper Company (hereinafter "Cooper") markets pharmaceutical specialties. It had constructed a categorical pricing policy that was more advantageous for dispensing pharmacies and their groupings than for wholesalers. Pyxis Pharma ('Pyxis'), which has the status of a purchasing grouping structure (SRA), acting in partnership with Sagitta Pharma ('Sagitta'), a pharmaceutical purchasing group (CAP), was refused access to the preferential conditions granted by Cooper to individual pharmacies and groups which had concluded a listing contract with it. To get around this refusal, Pyxis and Sagitta had pharmacies purchase products from Cooper on preferential

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Karine Biancone, General conditions of sale: The Paris Court of Appeal reviews the legality of the general conditions of sales by client categories’ criteria and their implementation (Pyxis Pharma / Cooper), 4 July 2019, Concurrences N° 4-2019, Art. N° 92217, www.concurrences.com

Visites 451

All reviews